Go to content
UR Home

Vasoplegic Syndrome after Oral Nimodipine Application in Patients with Subarachnoid Hemorrhage

Bele, Sylvia, Scheitzach, J., Kieninger, Martn, Hochreiter, A., Schödel, Petra, Bründl, Elisabeth, Schebesch, Karl-Michael and Brawanski, Alexander (2014) Vasoplegic Syndrome after Oral Nimodipine Application in Patients with Subarachnoid Hemorrhage. Journal of Anesthesia & Critical Care: Open Access 1 (6).

Download (1MB)
Date of publication of this fulltext: 05 Mar 2015 12:48

at publisher (via DOI)

Other URL: http://medcraveonline.com/JACCOA/JACCOA-01-00035.pdf


the underlying aneurysm leading to decrease of immediate complications such as rebleeding, cerebral vasospasm remains the major cause for mortality and morbidity after subarachnoid hemorrhage. The only FDA approved drug for treatment of cerebral vasospasm is the calcium antagonist Nimodipine that has shown beneficial effects on outcome. It is safe, cost efficient and the most widely studied drug ...


Export bibliographical data

Item type:Article
Date:2 December 2014
Institutions:Medicine > Lehrstuhl für Neurochirurgie
Projects:Open Access Publizieren (DFG)
Identification Number:
Keywords:Vasoplegic Syndrome oral nimodipine, Subarachnoid hemorrhage, Methylene blue application
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:31422
Owner only: item control page


Downloads per month over past year

  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons